Array CGH demonstrates characteristic aberration signatures in human papillary thyroid carcinomas governed by RET/PTC

作者：Unger K; Malisch E; Thomas G; Braselmann H; Walch A; Jackl G; Lewis P; Lengfelder E; Bogdanova T; Wienberg J; Zitzel**erger H^*

来源：Oncogene, 2008, 27(33): 4592-4602.

DOI：10.1038/onc.2008.99

• papillary thyroid carcinoma
• array CGH
• RET/PTC
• candidate genes
• tumour development
• aberration signature

The aim of this study is to investigate additional genetic alterations in papillary thyroid carcinomas (PTCs) with known RET/PTC rearrangements. We applied array-based comparative genomic hybridization (array CGH) to 33 PTC (20 PTC from adults, 13 post-Chernobyl PTC from children) with known RET/PTC status. Principal component analysis and hierarchical cluster analysis identified cases with similar aberration patterns. Significant deviations between tumour-groups were obtained by statistical testing (Fisher's exact test in combination with Benjamini-Hochberg FDR-controlling procedure). FISH analysis on FFPE sections was applied to validate the array CGH data. Deletions were found more frequently in RET/PTC-positive and RET/PTC-negative tumours than amplifications. Specific aberration signatures were identified that discriminated between RET/PTC-positive and RET/PTC-negative cases (aberrations on chromosomes 1p, 3q, 4p, 7p, 9p/q, 10q, 12q, 13q and 21q). In addition, childhood and adult RET/PTC-positive cases differ significantly for a deletion on the distal part of chromosome 1p. There are additional alterations in RET/PTC-positive tumours, which may act as modifiers of RET activation. In contrast, alterations in RET/PTC-negative tumours indicate alternative routes of tumour development. The data presented serve as a starting point for further studies on gene expression and function of genes identified in this study.

• 出版日期2008-7-31